Earnings Per Share
EPS (Diluted, Continuing)
STERIS EPS (Diluted, Continuing) increased by 14.8% to $2.25 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.0%, from $1.49 to $2.25. Over 4 years (FY 2022 to FY 2026), EPS (Diluted, Continuing) shows an upward trend with a 28.4% CAGR.
Analysis
StatementIncome Statement
SectionEarnings Per Share
First reportedQ1 2022
Last reportedQ4 2026May 29, 2026
Metric ID:
mrk_eps_diluted_continuing_operationsHistorical Data
20 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.73 | $0.73 | $0.73 | $0.73 | $1.19 | $1.24 | $1.32 | $1.84 | $1.32 | $1.21 | $1.50 | $1.55 | $1.41 | $1.52 | $1.76 | $1.49 | $1.80 | $1.95 | $1.96 | $2.25 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +62.5% | +4.2% | +6.5% | +39.4% | -28.3% | -8.3% | +24.0% | +3.3% | -9.0% | +7.8% | +15.8% | -15.3% | +20.8% | +8.3% | +0.5% | +14.8% |
| YoY Change | — | — | — | — | +62.5% | +69.3% | +80.2% | +151.2% | +10.9% | -2.4% | +13.6% | -15.8% | +6.8% | +25.6% | +17.3% | -3.9% | +27.7% | +28.3% | +11.4% | +51.0% |
Range$0.73 – $2.25
CAGR+26.7%
Avg YoY Growth+33.4%
Median YoY Growth+21.5%
Current Streak4 quarters growth
EPS (Diluted, Continuing) at Other Companies
Frequently Asked Questions
- What is STERIS's eps (diluted, continuing)?
- STERIS (STE) reported eps (diluted, continuing) of $2.25 in Q1 2026.
- How has STERIS's eps (diluted, continuing) changed year-over-year?
- STERIS's eps (diluted, continuing) increased by 51.0% year-over-year, from $1.49 to $2.25.
- What is the long-term trend for STERIS's eps (diluted, continuing)?
- Over 4 years (2022 to 2026), STERIS's eps (diluted, continuing) has grown at a 28.4% compound annual growth rate (CAGR), from $2.93 to $7.96.